Loading clinical trials...
Loading clinical trials...
A Randomized Phase II Study Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy Produced by Oxaliplatin
Conditions
Interventions
Duloxetine 60 mg qd
Lorcaserin
Locations
1
United States
Cancer Treatment Centers of America - Atlanta
Newnan, Georgia, United States
Start Date
June 1, 2019
Primary Completion Date
February 1, 2021
Completion Date
October 1, 2021
Last Updated
April 4, 2019
NCT07352514
NCT07064798
NCT07164950
NCT06994507
NCT04633655
NCT04970121
Lead Sponsor
Southeastern Regional Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions